INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 202 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $234,000 | -34.3% | 16,800 | -23.1% | 0.00% | 0.0% |
| Q4 2021 | $356,000 | -46.3% | 21,855 | -51.0% | 0.00% | -50.0% |
| Q3 2021 | $663,000 | -44.8% | 44,623 | -25.8% | 0.00% | -60.0% |
| Q2 2021 | $1,200,000 | +81.3% | 60,100 | +109.4% | 0.01% | +66.7% |
| Q1 2021 | $662,000 | +138.1% | 28,704 | +155.3% | 0.00% | +200.0% |
| Q4 2020 | $278,000 | -77.8% | 11,244 | -43.5% | 0.00% | -88.9% |
| Q1 2020 | $1,252,000 | +78.9% | 19,898 | +252.9% | 0.01% | +80.0% |
| Q4 2019 | $700,000 | -10.6% | 5,639 | -52.2% | 0.01% | -28.6% |
| Q3 2019 | $783,000 | +66.6% | 11,800 | +180.8% | 0.01% | +133.3% |
| Q1 2019 | $470,000 | -2.1% | 4,202 | +10.6% | 0.00% | 0.0% |
| Q3 2018 | $480,000 | – | 3,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |